• News
  • BioTech

La Jolla Pharma, Senomyx added to Russell indexes

At least two local drug firms were added to the Russell stock indexes when they were reconfigured last week, designed to provide a barometer for smaller stocks trading on the national exchanges.

La Jolla Pharmaceutical Co. (Nasdaq: LJPC), which develops therapies for life-threatening diseases, and Senomyx Inc. (Nasdaq: SNMX), which develops novel flavors for foods and beverages, were both added to the Russell Microcap Index comprising the smallest 1,000 securities in the Russell 2000 Index.

George Tidmarsh, La Jolla Pharmaceutical’s CEO, says he expects that inclusion in the index “will increase the liquidity of our stock and expose us to a wide range of institutions, investors and index funds that reference them.”

Inclusion on the microcap list also means the firms are now on the Russell 2000 and Russell 3000 lists.

User Response
0 UserComments

La Jolla Pharmaceutical Co.

Company Website

6455 Nancy Ridge Dr.
San Diego, CA 92121

La Jolla Pharmaceutical Co. Executive(s):

Deirdre Gillespie

  • Chief Executive Officer, President

George Tidmarsh

  • Chief Executive Officer, President

Similar Companies

NAICS - 541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)